Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regenxbio

8.36
-1.7200-17.06%
Post-market: 8.450.0900+1.08%19:45 EDT
Volume:2.65M
Turnover:22.62M
Market Cap:419.34M
PE:-2.70
High:9.86
Open:9.72
Low:7.95
Close:10.08
Loading ...

Raymond James Sticks to Their Buy Rating for RegenXBio (RGNX)

TIPRANKS
·
11 hours ago

Crude Oil Moves Higher; Ciena Posts Downbeat Earnings

Benzinga
·
12 hours ago

BUZZ-U.S. STOCKS ON THE MOVE-Texas Instruments, Broadcom, Circle

Reuters
·
13 hours ago

BUZZ-U.S. STOCKS ON THE MOVE-PVH, Phio Pharma, Cracker Barrel

Reuters
·
Yesterday

Regenxbio’s RGX-202 shows efficacy in Phase 1/2 Duchenne trial

TIPRANKS
·
Yesterday

Regenxbio Inc. Announces Positive Interim Data from Phase I/II Trial of RGX-202 for Duchenne Muscular Dystrophy

Reuters
·
Yesterday

Regenxbio Inc - Pivotal Trial Expected to Support Bla Submission Using Accelerated Approval Pathway in Mid-2026

THOMSON REUTERS
·
Yesterday

Regenxbio Reports New Positive Functional Data From Phase I/Ii Affinity Duchenne® Trial of Rgx-202

THOMSON REUTERS
·
Yesterday

Regenxbio Inc - Favorable Safety Profile Continues With No Serious Adverse Events Observed in Rgx-202 Trial

THOMSON REUTERS
·
Yesterday

Regenxbio Inc -Expects to Share Top-Line Data in First Half of 2026

THOMSON REUTERS
·
Yesterday

Regenxbio Inc. Conducted Annual Stockholders Meeting

Reuters
·
04 Jun

Regenxbio Inc. to Release Interim Functional Data from Phase I/II AFFINITY DUCHENNE® Trial

Reuters
·
02 Jun

RegenXBio (RGNX) Receives a Buy from Leerink Partners

TIPRANKS
·
28 May

Regenxbio Inc : Leerink Partners Cuts Target Price to $22 From $24

THOMSON REUTERS
·
20 May

Regenxbio Signs Royalty Deal Worth Up to $250 Million With Healthcare Royalty

MT Newswires Live
·
20 May

BRIEF-Regenxbio Announces Strategic Royalty Monetization Agreement For Up To $250 Million

Reuters
·
20 May

Regenxbio Secures Up to $250 Million Royalty Monetization Agreement with HCRx

Reuters
·
20 May

Regenxbio signs strategic royalty monetization agreement for up to $250M

TIPRANKS
·
20 May

Regenxbio Inc - Receives $150 Mln, Extends Cash Runway to 2027

THOMSON REUTERS
·
20 May

Regenxbio Announces Strategic Royalty Monetization Agreement for up to $250 Million

THOMSON REUTERS
·
20 May